Skip to search formSkip to main contentSkip to account menu

NSC 651016

Known as: NSC-651016 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Naphthalenesulfonates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
New advances in HIV entry inhibitors development.
Considerable advances have been made in the last years in the design of derivatives acting as inhibitors of HIV entry and fusion… 
2002
2002
Suradista NSC 651016 inhibits the angiogenic activity of CXCL12-stromal cell-derived factor 1alpha.
CXCL12 (stromal cell-derived factor 1alpha), a ligand for CXCR4, has been shown to induce endothelial cell chemotaxis and to… 
2002
2002
Suradista NSC 651016 Inhibits the Angiogenic Activity of CXCL12-Stromal Cell-derived Factor 1 (cid:1) 1
CXCL12 (stromal cell-derived factor 1 (cid:1) ), a ligand for CXCR4, has been shown to induce endothelial cell chemotaxis and to… 
Highly Cited
1998
Highly Cited
1998
Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application.
Select chemokine receptors act as coreceptors for HIV-1 entry into human cells and represent targets for antiviral therapy. In… 
Review
1998
Review
1998
Small molecule inhibitor of HIV‐1 cell fusion blocks chemokine receptor‐mediated function
The intersection of the HIV and the chemokine fields began with the observation that HIV entry into cells could be blocked by… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)